Literature DB >> 29204788

Modeling Drug Disposition and Drug-Drug Interactions Through Hypothesis-Driven Physiologically Based Pharmacokinetics: a Reversal Translation Perspective.

Guo-Fu Li1,2, Qing-Shan Zheng3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29204788     DOI： 10.1007/s13318-017-0452-8

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN： 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  20 in total

1.  A comparison of relative abundance, activity factor and inhibitory monoclonal antibody approaches in the characterization of human CYP enzymology.

Authors:  Matthew G Soars; Harry V Gelboin; Kristopher W Krausz; Robert J Riley
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

2.  Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Authors:  Hayley S Brown; Kiyomi Ito; Aleksandra Galetin; J Brian Houston
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

3.  Ethnic-specific in vitro-in vivo extrapolation and physiologically based pharmacokinetic approaches to predict cytochrome P450-mediated pharmacokinetics in the Chinese population: opportunities and challenges.

Authors:  Guo-Fu Li; Guo Yu; Hong-Xia Liu; Qing-Shan Zheng
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

Review 4.  Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspective.

Authors:  Guo Yu; Qing-Shan Zheng; Guo-Fu Li
Journal:  AAPS J       Date:  2014-09-03       Impact factor: 4.009

5.  The metabolic fate of tolbutamide in man and in the rat.

Authors:  R C Thomas; G J Ikeda
Journal:  J Med Chem       Date:  1966-07       Impact factor: 7.446

6.  Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure.

Authors:  Anne-Charlotte Castellan; Michel Tod; François Gueyffier; Mélanie Audars; Fredéric Cambriels; Behrouz Kassaï; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447

7.  Cytochrome P450 2C9 mediated metabolism in people with and without cancer.

Authors:  S S Shord; L H Cavallari; M A G Viana; K Momary; J Neceskas; R E Molokie; K Deyo; S R Patel
Journal:  Int J Clin Pharmacol Ther       Date:  2008-07       Impact factor: 1.366

8.  Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.

Authors:  Zoe E Barter; Geoffrey T Tucker; Karen Rowland-Yeo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 9.  Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs.

Authors:  Emily Schwenger; Venkatesh Pilla Reddy; Ganesh Moorthy; Pradeep Sharma; Helen Tomkinson; Eric Masson; Karthick Vishwanathan
Journal:  Clin Pharmacol Ther       Date:  2017-11-20       Impact factor: 6.875

10.  Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5.

Authors:  K Yoshida; B Sun; L Zhang; P Zhao; D R Abernethy; T D Nolin; A Rostami-Hodjegan; I Zineh; S-M Huang
Journal:  Clin Pharmacol Ther       Date:  2016-03-07       Impact factor: 6.875
View more
  4 in total

1.  Model-Informed Approaches for Alternative Aripiprazole Dosing Regimens and Missed Dose Management: Towards Better Adherence to Antipsychotic Pharmacotherapy.

Authors:  Jun-Yi Wu; Guo Yu; Guo-Fu Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-08       Impact factor: 2.441

2.  Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.

Authors:  Guo Yu; Hong-Hao Zhou; Qing-Shan Zheng; Guo-Fu Li
Journal:  Eur J Clin Pharmacol       Date:  2018-12-19       Impact factor: 2.953

3.  Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.

Authors:  Guo-Fu Li; Qing-Shan Zheng; Yichao Yu; Wei Zhong; Hong-Hao Zhou; Furong Qiu; Guangji Wang; Guo Yu; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

4.  Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.

Authors:  Guo Yu; Guo-Fu Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-02       Impact factor: 2.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.